Zanubrutinib User Reviews & Ratings (Page 3)
Brand names: Brukinsa
Zanubrutinib has an average rating of 8.7 out of 10 from a total of 58 reviews on Drugs.com. 81% of reviewers reported a positive experience, while 0% reported a negative experience.
Reviews for Zanubrutinib
- Bru...
- Taken for 6 months to 1 year
- August 23, 2024
For Chronic Lymphocytic Leukemia "Effective, results were noted within a couple of days. My issue was swelling around the eyes, which progressed over 5 months to a state where I could barely open my eyes."
- Ste...
- Taken for 6 months to 1 year
- December 16, 2024
Zanubrutinib for Waldenström Macroglobulinemia "Started 160 mg twice daily 8 months ago, IgM down to under 1000 from 5000. Hemoglobin from 8.5 to 15... minimal side effects. So far, so good."
See also:
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Epkinly
Epkinly is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Frequently asked questions
- Kay...
- Taken for 6 months to 1 year
- June 29, 2024
For Waldenström Macroglobulinemia "Very few side effects. Minor if any most days. Easy to take and simple to maintain correct dosage daily. IGM and viscosity going down. Pleased."
- raf...
- Taken for 1 to 6 months
- January 27, 2024
Zanubrutinib for Mantle Cell Lymphoma "Other than tingling of skin in my arms and occasional red spots that go away in about a week, I feel good."
Are you taking this medicine?
Your review helps others make informed decisions.- bru...
- Taken for 1 to 6 months
- April 17, 2025
Zanubrutinib for Chronic Lymphocytic Leukemia "Slowed down and maybe improved energy levels after approx. 90 tablets and six weeks. Recently had plastic surgery and the wound will not heal. Leaking blood still after 40 hours."
- Pat...
- Taken for 6 months to 1 year
- May 4, 2025
For Waldenström Macroglobulinemia "So far, excellent result. If offered, take it, best thing ever. Little side effect except wind for 3 weeks. Been on it 7 months, paraprotein at 10 will drop more, I hope."
- LFD...
- Taken for 1 to 6 months
- March 9, 2025
For Mantle Cell Lymphoma "Used over 4 months as monotherapy. Regular scans confirm complete remission of node cancer. Minor skeletal ache and blurred vision, most notable side effects."
Are you taking this medicine?
Your review helps others make informed decisions.More about zanubrutinib
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Zanubrutinib for Waldenström Macroglobulinemia "After 4 months, blood work improving, m protein levels dropping from 5000 down to 1700, with a hemoglobin rise. No appreciable side effects so far. 2 80 mg twice daily."